Pierre Ecclestone
Corporate Officer/Principal chez VALEO PHARMA INC.
Fortune : - $ au 30/04/2024
Profil
Pierre Ecclestone is currently the Vice President of Business Development at Valeo Pharma, Inc. since 2023.
Prior to this, he held the same position at Aralez Pharmaceuticals Canada, Inc. from 2021 to 2023.
Before that, he worked as a Principal at Pce Pharma Consulting, Inc. from 2017 to 2021.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VALEO PHARMA INC CLASS A
-.--% | 13/09/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Pierre Ecclestone
| Sociétés | Poste | Début |
|---|---|---|
| VALEO PHARMA INC. | Corporate Officer/Principal | 01/08/2023 |
Anciens postes connus de Pierre Ecclestone
| Sociétés | Poste | Fin |
|---|---|---|
| TRIBUTE PHARMACEUTICALS CANADA INC | Corporate Officer/Principal | 01/04/2023 |
| Pce Pharma Consulting, Inc. | Corporate Officer/Principal | 01/01/2021 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VALEO PHARMA INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Aralez Pharmaceuticals Canada, Inc.
 Aralez Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Aralez Pharmaceuticals Canada, Inc. operates as a pharmaceutical company which focuses on the acquisition, licensing, development, and promotion of healthcare products. It also sells Uracyst and NeoVisc internationally through a number of strategic partnerships. The company was founded by Peter Roy Riehl and Robert Paul Harris on November 14, 1994 and is headquartered in Mississauga, Canada. | Health Technology |
| Pce Pharma Consulting, Inc. |